Menu

Drugmaker GSK owes refunds to certain 340B providers for its asthma product Nucala, a notice posted to a government site said.

GSK Posts 340B Refund Notice on High-Revenue Asthma Treatment

February 6, 2024 Rich Daly Editor in Chief Views

Drugmaker GlaxoSmithKline has posted another refund notice to 340B providers related to purchases of its high-earning asthma drugs. A Jan. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly